A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis
Status:
Completed
Trial end date:
2019-05-03
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy and safety of ixekizumab in tumor
necrosis factor (TNF) inhibitor-experienced participants with radiographic axial
spondyloarthritis (rad-axSpA).